Perinatal Depression & Anxiety: Relationships with Late Pregnancy Thyroid Status

围产期抑郁症

基本信息

项目摘要

DESCRIPTION (provided by applicant): Up to 30 percent of postpartum women develop depressive symptoms and 14% develop major or minor depression. Although relationships between thyroid status and depression are well established in the general population and large thyroid changes occur during and following pregnancy, there have been few studies of thyroid function in pre or postpartum (perinatal) depression. We found robustly significant correlations between low, euthyroid range total and free thyroxine (TT4, FT4) concentrations during late pregnancy and higher perinatal depression self-ratings. Postpartum TSH levels fell significantly in mothers with low depression but did not decline and were significantly more elevated in mothers who were more depressed. A significantly higher fraction of mothers with depression history had lower prepartum TT4 & FT4 concentrations. We will test the validity of our findings in a larger cohort (N = 200), determine if lower late pregnancy TT4 & FT4 levels are also related to perinatal syndromal (major or minor) depression or anxiety symptoms or disorders, ascertain whether lower prepartum TT4 & FT4 levels are related to depression history and test whether prenatal thyroid measures improve prediction of postpartum depression especially when combined with known risk factors (abuse history, stressful life events, low social support). We hypothesize that perinatal depression is related to greater sensitivity to suppression of the HPT axis by sex hormone and possibly cortisol elevations during pregnancy producing lower prepartum TT4 & FT4 levels. This results in a surge of central drive in the HPT axis after the rapid postpartum drop in these hormone levels producing higher postpartum TSH levels. Indices of increased central drive in the HPT axis (elevated CSF TRH concentrations, blunted TSH release by TRH) are associated with major depression. To test our theory, we will determine if lower antenatal TT4 & FT4 levels are significantly related to higher postpartum TSH levels and if that relationship is associated with perinatal depression. We will also examine if there are interactions between late pregnancy sex hormone and cortisol levels and late pregnancy TT4 & FT4 levels in predicting perinatal depression. PUBLIC HEALTH RELEVANCE: About 14% of mothers develop clinical depression within the first 3 months after giving birth and a similar percentage become depressed during pregnancy. This project is based on two preliminary studies that found that mothers who are more depressed postpartum have relatively low (but normal range) thyroid hormone levels during late pregnancy but then have higher levels of other thyroid hormones after giving birth. The goals of this project are to see if these results are confirmed in a much larger number of pregnant and postpartum women, if thyroid hormone levels during late pregnancy might help predict which mothers will become depressed, if pre or postpartum thyroid measures are related to anxiety symptoms or disorders (which are also common in the postpartum period) and to test a theory about how lower late pregnancy thyroid hormone levels might contribute to postpartum depression.
描述(由申请人提供):多达30%的产后妇女出现抑郁症状,14%出现重度或轻度抑郁症。虽然甲状腺状态和抑郁症之间的关系是在一般人群中建立和大的甲状腺变化发生在怀孕期间和之后,很少有研究甲状腺功能在产前或产后(围产期)抑郁症。我们发现,妊娠晚期甲状腺功能正常范围内的总甲状腺素和游离甲状腺素(TT4,FT4)浓度较低与围产期抑郁症自我评分较高之间存在显著相关性。产后TSH水平显着下降的母亲与低抑郁症,但没有下降,显着更高的母亲谁是更抑郁。一个显着较高比例的母亲与抑郁症的历史有较低的垂体TT4和FT4浓度。我们将在一个更大的队列(N = 200)中检验我们研究结果的有效性,确定妊娠晚期较低的TT4和FT4水平是否也与围产期综合征有关。(主要或次要)抑郁或焦虑症状或障碍,确定下丘脑TT4和FT4水平与抑郁症病史有关,并测试产前甲状腺测量是否能改善产后抑郁症的预测,特别是当两者结合时。已知的风险因素(虐待史,压力生活事件,低社会支持)。我们推测,围产期抑郁症与性激素对HPT轴抑制的更大敏感性有关,可能与妊娠期间皮质醇升高产生较低的垂体TT4和FT4水平有关。这导致产后这些激素水平快速下降后,HPT轴的中央驱动激增,产生更高的产后TSH水平。HPT轴中枢驱动力增加的指标(CSF中TRH浓度升高,TRH释放TSH减弱)与重度抑郁症相关。为了验证我们的理论,我们将确定较低的产前TT4和FT4水平是否与较高的产后TSH水平显著相关,以及这种关系是否与围产期抑郁症有关。本研究亦将探讨孕晚期性激素及皮质醇水平与孕晚期TT4及FT4水平在预测围产期抑郁症时是否有交互作用。公共卫生相关性:大约14%的母亲在产后的前3个月内出现临床抑郁症,同样比例的母亲在怀孕期间出现抑郁症。该项目基于两项初步研究,发现产后抑郁的母亲在怀孕后期甲状腺激素水平相对较低(但正常范围),但在分娩后其他甲状腺激素水平较高。这个项目的目标是看看这些结果是否在更多的孕妇和产后妇女中得到证实,如果怀孕后期的甲状腺激素水平可能有助于预测哪些母亲会变得抑郁,如果产前或产后甲状腺测量与焦虑症状或障碍有关,(这在产后时期也很常见),并测试一个关于怀孕后期甲状腺激素水平降低可能导致产后抑郁症的理论。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CORT ANDREW PEDERSEN其他文献

CORT ANDREW PEDERSEN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CORT ANDREW PEDERSEN', 18)}}的其他基金

Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
催产素治疗精神分裂症的社会认知和功能缺陷
  • 批准号:
    8258234
  • 财政年份:
    2011
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
催产素治疗精神分裂症的社会认知和功能缺陷
  • 批准号:
    8087450
  • 财政年份:
    2011
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin Treatment of Social Cognitive and Functional Deficits in Schizophrenia
催产素治疗精神分裂症的社会认知和功能缺陷
  • 批准号:
    8417003
  • 财政年份:
    2011
  • 资助金额:
    $ 56.58万
  • 项目类别:
Perinatal Depression & Anxiety: Relationships with Late Pregnancy Thyroid Status
围产期抑郁症
  • 批准号:
    8018551
  • 财政年份:
    2008
  • 资助金额:
    $ 56.58万
  • 项目类别:
Perinatal Depression & Anxiety: Relationships with Late Pregnancy Thyroid Status
围产期抑郁症
  • 批准号:
    8212222
  • 财政年份:
    2008
  • 资助金额:
    $ 56.58万
  • 项目类别:
Perinatal Depression & Anxiety: Relationships with Late Pregnancy Thyroid Status
围产期抑郁症
  • 批准号:
    7761735
  • 财政年份:
    2008
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin, Postnatal Experience & Adult Maternal Behavior
催产素,产后经历
  • 批准号:
    6856586
  • 财政年份:
    2002
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin, Postnatal Experience & Adult Maternal Behavior
催产素,产后经历
  • 批准号:
    6479620
  • 财政年份:
    2002
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin, Postnatal Experience & Adult Maternal Behavior
催产素,产后经历
  • 批准号:
    7037424
  • 财政年份:
    2002
  • 资助金额:
    $ 56.58万
  • 项目类别:
Oxytocin, Postnatal Experience & Adult Maternal Behavior
催产素,产后经历
  • 批准号:
    6625856
  • 财政年份:
    2002
  • 资助金额:
    $ 56.58万
  • 项目类别:

相似海外基金

Using generative AI combined with immersive technology to treat anxiety disorders
利用生成式人工智能结合沉浸式技术治疗焦虑症
  • 批准号:
    10109165
  • 财政年份:
    2024
  • 资助金额:
    $ 56.58万
  • 项目类别:
    Launchpad
Integration of stepped care for Perinatal Mood and Anxiety Disorders among Women Living with HIV in Kenya
肯尼亚艾滋病毒感染妇女围产期情绪和焦虑障碍的分级护理一体化
  • 批准号:
    10677075
  • 财政年份:
    2023
  • 资助金额:
    $ 56.58万
  • 项目类别:
Understanding the Effects of Adolescent Nicotine Exposure on Increased Risk for Mood and Anxiety Disorders: Bridging the Gap from Pre-Clinical to Clinical Investigations
了解青少年尼古丁暴露对情绪和焦虑障碍风险增加的影响:弥合临床前研究与临床研究之间的差距
  • 批准号:
    478121
  • 财政年份:
    2023
  • 资助金额:
    $ 56.58万
  • 项目类别:
    Operating Grants
Addressing perinatal mood and anxiety disorders (PMADs) through a doula intervention
通过导乐干预解决围产期情绪和焦虑障碍 (PMAD)
  • 批准号:
    10861961
  • 财政年份:
    2023
  • 资助金额:
    $ 56.58万
  • 项目类别:
Evaluation of the effectiveness and implementation of online group cognitive behavioral therapy for perinatal women with anxiety disorders.
评估在线团体认知行为治疗对患有焦虑症的围产期妇女的有效性和实施情况。
  • 批准号:
    22KJ3164
  • 财政年份:
    2023
  • 资助金额:
    $ 56.58万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Investigating the error-related negativity and the balance N1 in children with anxiety disorders
调查焦虑症儿童的错误相关消极性和平衡 N1
  • 批准号:
    10685283
  • 财政年份:
    2022
  • 资助金额:
    $ 56.58万
  • 项目类别:
RESONY: Digital therapeutic to manage anxiety disorders
RESONY:管理焦虑症的数字疗法
  • 批准号:
    10042996
  • 财政年份:
    2022
  • 资助金额:
    $ 56.58万
  • 项目类别:
    Grant for R&D
Augmenting the Efficacy of Benzodiazepine Taper with Telehealth-Delivered Cognitive Behavioral Therapy for Anxiety Disorders in Patients Using Prescription Opioids
通过远程医疗提供的认知行为疗法来增强苯二氮卓类药物逐渐减少的疗效,以治疗使用处方阿片类药物的焦虑症患者
  • 批准号:
    10705005
  • 财政年份:
    2022
  • 资助金额:
    $ 56.58万
  • 项目类别:
Developing an adjunctive mobile application for co-morbid substance use and anxiety disorders: comprehensive user experience testing of the Unwinding Anxiety application
开发针对共病药物使用和焦虑症的辅助移动应用程序:Unwinding Anxiety 应用程序的综合用户体验测试
  • 批准号:
    10597521
  • 财政年份:
    2022
  • 资助金额:
    $ 56.58万
  • 项目类别:
Investigating the role of neuroinflammation in environmental exposure-induced anxiety disorders
研究神经炎症在环境暴露诱发的焦虑症中的作用
  • 批准号:
    10573948
  • 财政年份:
    2022
  • 资助金额:
    $ 56.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了